Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 951

1.

Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.

Kawagoe S, Nakano M, Uchino K, Arimizu K, Kajitani T, Shimokawa H, Kusumoto T, Ikejiri K, Baba E.

Mol Clin Oncol. 2019 Sep;11(3):243-251. doi: 10.3892/mco.2019.1894. Epub 2019 Jul 4.

2.

Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.

Tsutsui H, Momomura SI, Yamashina A, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Yano M, Yamamoto K, Ako J, Inomata T, Sakata Y, Tanaka T, Kawasaki Y; J-SHIFT Study Investigators.

Circ J. 2019 Aug 8. doi: 10.1253/circj.CJ-19-0227. [Epub ahead of print]

3.

Disappearance of Angiodysplasia Following Transcatheter Aortic Valve Implantation in a Patient with Heyde's Syndrome: A Case Report and Review of the Literature.

Tsuchiya S, Matsumoto Y, Doman T, Fujiya T, Sugisawa J, Suda A, Sato K, Ikeda S, Shindo T, Kikuchi Y, Hao K, Takahashi J, Hatta W, Koike T, Masamune A, Saiki Y, Horiuchi H, Shimokawa H.

J Atheroscler Thromb. 2019 Aug 3. doi: 10.5551/jat.49239. [Epub ahead of print]

4.

Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 Aug 2. doi: 10.1007/s00380-019-01479-x. [Epub ahead of print]

PMID:
31375917
5.

Association between temporal changes in C-reactive protein levels and prognosis in patients with previous myocardial infarction - A report from the CHART-2 Study.

Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Saga C, Ikeno Y, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators.

Int J Cardiol. 2019 Jul 12. pii: S0167-5273(19)30080-4. doi: 10.1016/j.ijcard.2019.07.022. [Epub ahead of print]

PMID:
31358306
6.

Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension.

Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M.

Int J Cardiol. 2019 Jul 8. pii: S0167-5273(19)30008-7. doi: 10.1016/j.ijcard.2019.07.018. [Epub ahead of print]

PMID:
31350036
7.

Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.

Satoh K, Kikuchi N, Kurosawa R, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24. No abstract available.

PMID:
31339778
8.

Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.

Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, Sormani P, Aoki T, Sugimura K, Sawamura A, Okumura T, Pinney S, Hong K, Shah P, Braun Ö, Van de Heyning CM, Montero S, Petrella D, Huang F, Schmidt M, Raineri C, Lala A, Varrenti M, Foà A, Leone O, Gentile P, Artico J, Agostini V, Patel R, Garascia A, Van Craenenbroeck EM, Hirose K, Isotani A, Murohara T, Arita Y, Sionis A, Fabris E, Hashem S, Garcia-Hernando V, Oliva F, Greenberg B, Shimokawa H, Sinagra G, Adler ED, Frigerio M, Camici PG.

J Am Coll Cardiol. 2019 Jul 23;74(3):299-311. doi: 10.1016/j.jacc.2019.04.063.

PMID:
31319912
9.

Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.

Chiba T, Nakano M, Hasebe Y, Kimura Y, Fukasawa K, Miki K, Morosawa S, Takanami K, Ota H, Fukuda K, Shimokawa H.

J Cardiol. 2019 Jul 2. pii: S0914-5087(19)30152-2. doi: 10.1016/j.jjcc.2019.04.016. [Epub ahead of print]

PMID:
31277963
10.

Diabetes care providers' manual for disaster diabetes care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

Diabetol Int. 2019 Jun 14;10(3):153-179. doi: 10.1007/s13340-019-00397-7. eCollection 2019 Jul.

PMID:
31275782
11.

Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.

Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M.

Respirology. 2019 Jul 1. doi: 10.1111/resp.13618. [Epub ahead of print]

PMID:
31261445
12.

Successful Management of Acute Congestive Heart Failure by Emergent Caesarean Section Followed by Adrenalectomy in a Pregnant Woman with Cushing's Syndrome-induced Cardiomyopathy.

Sakota M, Tatebe S, Sugimura K, Aoki T, Yamamoto S, Sato H, Kikuchi N, Konno R, Terui Y, Satoh K, Tezuka Y, Morimoto R, Saito M, Kuniyoshi S, Shimokawa H.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2427-18. [Epub ahead of print]

13.

Diabetes Care Providers' Manual for Disaster Diabetes Care.

Satoh J, Yokono K, Ando R, Asakura T, Hanzawa K, Ishigaki Y, Kadowaki T, Kasuga M, Katagiri H, Kato Y, Kurosawa K, Miura M, Nakamura J, Nishitsuka K, Ogawa S, Okamoto T, Sakuma S, Sakurai S, Satoh H, Shimauchi H, Shimokawa H, Shoji W, Sugiyama T, Suwabe A, Tachi M, Takahashi K, Takahashi S, Terayama Y, Tomita H, Tsuchiya Y, Waki H, Watanabe T, Yahata K, Yamashita H.

J Diabetes Investig. 2019 Jul;10(4):1118-1142. doi: 10.1111/jdi.13053. Epub 2019 Jun 14.

14.

Different characteristics of postoperative atrial tachyarrhythmias between congenital and non-congenital heart disease.

Kondo M, Fukuda K, Wakayama Y, Nakano M, Hasebe Y, Satake H, Segawa M, Hirano M, Shimokawa H.

J Interv Card Electrophysiol. 2019 Jun 13. doi: 10.1007/s10840-019-00575-2. [Epub ahead of print]

PMID:
31197584
15.

Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.

Kurosawa R, Satoh K, Kikuchi N, Kikuchi H, Saigusa D, Al-Mamun ME, Siddique MAH, Omura J, Satoh T, Sunamura S, Nogi M, Numano K, Miyata S, Uruno A, Kano K, Matsumoto Y, Doi T, Aoki J, Oshima Y, Yamamoto M, Shimokawa H.

Circ Res. 2019 Jul 19;125(3):309-327. doi: 10.1161/CIRCRESAHA.119.315229. Epub 2019 Jun 14.

PMID:
31195886
16.

Coronary Artery Spasm and Perivascular Adipose Tissue Inflammation: Insights From Translational Imaging Research.

Ohyama K, Matsumoto Y, Shimokawa H.

Eur Cardiol. 2019 Apr;14(1):6-9. doi: 10.15420/ecr.2019.3.2. Review.

17.

Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 May 24. doi: 10.1007/s00380-019-01425-x. [Epub ahead of print] Erratum in: Heart Vessels. 2019 Aug 2;:.

PMID:
31127325
18.

Recent Advances in the Understanding of Thrombosis.

Satoh K, Satoh T, Yaoita N, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):e159-e165. doi: 10.1161/ATVBAHA.119.312003. No abstract available.

PMID:
31116608
19.

Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.

Oikawa T, Sakata Y, Nochioka K, Miura M, Abe R, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators.

Int J Cardiol. 2019 Sep 1;290:106-112. doi: 10.1016/j.ijcard.2019.04.078. Epub 2019 Apr 26.

PMID:
31104823
20.

Characteristics of ventricular tachycardia and long-term treatment outcome in patients with dilated cardiomyopathy complicated by lamin A/C gene mutations.

Hasebe Y, Fukuda K, Nakano M, Kumagai K, Karibe A, Fujishima F, Satake H, Kondo M, Wakayama Y, Shimokawa H.

J Cardiol. 2019 May 3. pii: S0914-5087(19)30101-7. doi: 10.1016/j.jjcc.2019.03.019. [Epub ahead of print]

PMID:
31060954
21.
22.

JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Takahashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T; Japanese Circulation Society Joint Working Group.

Circ J. 2019 Apr 25;83(5):1085-1196. doi: 10.1253/circj.CJ-19-0133. Epub 2019 Mar 29. No abstract available.

23.

Risk factors and localization of silent cerebral infarction in patients with atrial fibrillation.

Miki K, Nakano M, Aizawa K, Hasebe Y, Kimura Y, Morosawa S, Akashi T, Morishita Y, Miyata S, Fukuda K, Shimokawa H.

Heart Rhythm. 2019 Mar 18. pii: S1547-5271(19)30235-8. doi: 10.1016/j.hrthm.2019.03.013. [Epub ahead of print]

PMID:
30898584
24.

Micro-Optical Coherence Tomography for Endothelial Cell Visualization in the Coronary Arteries.

Nishimiya K, Yin B, Piao Z, Ryu J, Osman H, Leung HM, Sharma G, Liang CP, Gardecki JA, Zheng H, Shimokawa H, Tearney GJ.

JACC Cardiovasc Imaging. 2019 Mar 13. pii: S1936-878X(19)30151-2. doi: 10.1016/j.jcmg.2019.01.021. [Epub ahead of print] No abstract available.

PMID:
30878431
25.

Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment.

Suzuki K, Oikawa T, Nochioka K, Miura M, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Takahashi J, Miyata S, Sakata Y, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 May;39(5):934-944. doi: 10.1161/ATVBAHA.119.312336.

PMID:
30866657
26.

Treadmill exercise prevents reduction of bone mineral density after myocardial infarction in apolipoprotein E-deficient mice.

Kanazawa M, Matsumoto Y, Takahashi K, Suzuki H, Uzuka H, Nishimiya K, Shimokawa H.

Eur J Prev Cardiol. 2019 Mar 11:2047487319834399. doi: 10.1177/2047487319834399. [Epub ahead of print]

PMID:
30857427
27.

Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).

Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H, Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H; Japanese Circulation Society and the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Joint Working Group.

Circ J. 2019 Mar 25;83(4):842-945. doi: 10.1253/circj.CJ-66-0158. Epub 2019 Mar 9. No abstract available.

28.

Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina: Ethnic differences detected in an international comparative study.

Sato K, Takahashi J, Odaka Y, Suda A, Sueda S, Teragawa H, Ishii K, Kiyooka T, Hirayama A, Sumiyoshi T, Tanabe Y, Kimura K, Kaikita K, Ong P, Sechtem U, Camici PG, Kaski JC, Crea F, Beltrame JF, Shimokawa H; Japanese Coronary Spasm Association.

Int J Cardiol. 2019 Sep 15;291:13-18. doi: 10.1016/j.ijcard.2019.02.038. Epub 2019 Feb 20.

PMID:
30819587
29.

Cardiac Lymphatic Dysfunction Causes Drug-Eluting Stent-Induced Coronary Hyperconstricting Responses in Pigs In Vivo.

Amamizu H, Matsumoto Y, Morosawa S, Ohyama K, Uzuka H, Hirano M, Nishimiya K, Gokon Y, Watanabe-Asaka T, Hayashi M, Miyata S, Kamei T, Kawai Y, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):741-753. doi: 10.1161/ATVBAHA.119.312396.

PMID:
30816801
30.

Important roles of endothelial caveolin-1 in endothelium-dependent hyperpolarization and ischemic angiogenesis in mice.

Ito A, Shiroto T, Godo S, Saito H, Tanaka S, Ikumi Y, Kajitani S, Satoh K, Shimokawa H.

Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H900-H910. doi: 10.1152/ajpheart.00589.2018. Epub 2019 Feb 1.

PMID:
30707613
31.

Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease.

Sato H, Sugimura K, Miura M, Konno R, Kozu K, Yaoita N, Shimizu T, Yamamoto S, Aoki T, Tatebe S, Satoh K, Shimokawa H.

Tohoku J Exp Med. 2019 Feb;247(2):69-73. doi: 10.1620/tjem.247.69.

32.

Response by Kikuchi et al Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target".

Kikuchi N, Satoh K, Saito Y, Shimokawa H.

Circulation. 2019 Jan 29;139(5):724-725. doi: 10.1161/CIRCULATIONAHA.118.038479. No abstract available.

PMID:
30689421
33.

Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with cardiovascular diseases.

Kasahara S, Sakata Y, Nochioka K, Miura M, Abe R, Sato M, Aoyanagi H, Fujihashi T, Yamanaka S, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H.

Int J Cardiol. 2019 Apr 1;280:184-189. doi: 10.1016/j.ijcard.2018.12.069. Epub 2019 Jan 7.

PMID:
30685104
34.

Sex hormones in heart failure revisited?

Nagai M, Förster CY, Dote K, Shimokawa H.

Eur J Heart Fail. 2019 Mar;21(3):308-310. doi: 10.1002/ejhf.1408. Epub 2019 Jan 22. No abstract available.

PMID:
30666765
35.

Development of a Shock-Wave Catheter Ablation System for Ventricular Tachyarrhythmias: Validation Study in Pigs In Vivo.

Morosawa S, Yamamoto H, Hirano M, Amamizu H, Uzuka H, Ohyama K, Hasebe Y, Nakano M, Fukuda K, Takayama K, Shimokawa H.

J Am Heart Assoc. 2019 Jan 22;8(2):e011038. doi: 10.1161/JAHA.118.011038.

36.

Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats.

Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S.

Clin Exp Nephrol. 2019 May;23(5):597-605. doi: 10.1007/s10157-019-01689-7. Epub 2019 Jan 7.

PMID:
30617840
37.

Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.

Crea F, Bairey Merz CN, Beltrame JF, Berry C, Camici PG, Kaski JC, Ong P, Pepine CJ, Sechtem U, Shimokawa H.

Eur Heart J. 2019 Jan 4. doi: 10.1093/eurheartj/ehy857. [Epub ahead of print]

PMID:
30608528
38.

Gender differences in prognostic relevance of self-care behaviors on mortality and hospitalization in patients with heart failure - A report from the CHART-2 Study.

Abe R, Sakata Y, Nochioka K, Miura M, Oikawa T, Kasahara S, Sato M, Aoyanagi H, Shiroto T, Sugimura K, Takahashi J, Miyata S, Shimokawa H; CHART-2 Investigators.

J Cardiol. 2019 May;73(5):370-378. doi: 10.1016/j.jjcc.2018.11.006. Epub 2018 Dec 31.

PMID:
30606681
39.

Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.

Yoshihiro T, Kusaba H, Makiyama A, Kobayashi K, Uenomachi M, Ito M, Doi Y, Mitsugi K, Aikawa T, Takayoshi K, Esaki T, Shimokawa H, Tsuchihashi K, Ariyama H, Akashi K, Baba E.

Int J Clin Oncol. 2019 May;24(5):508-515. doi: 10.1007/s10147-018-01391-w. Epub 2019 Jan 2.

PMID:
30604155
40.

Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.

Ikeda S, Mizushima W, Sciarretta S, Abdellatif M, Zhai P, Mukai R, Fefelova N, Oka SI, Nakamura M, Del Re DP, Farrance I, Park JY, Tian B, Xie LH, Kumar M, Hsu CP, Sadayappan S, Shimokawa H, Lim DS, Sadoshima J.

Circ Res. 2019 Jan 18;124(2):292-305. doi: 10.1161/CIRCRESAHA.118.314048.

PMID:
30582455
41.

Prognostic Significance of PR Interval Prolongation in Adult Patients With Total Correction of Tetralogy of Fallot.

Kimura Y, Fukuda K, Nakano M, Hasebe Y, Fukasawa K, Chiba T, Miki K, Tatebe S, Miyata S, Ota H, Kimura M, Adachi O, Saiki Y, Shimokawa H.

Circ Arrhythm Electrophysiol. 2018 Nov;11(11):e006234. doi: 10.1161/CIRCEP.118.006234.

PMID:
30571179
42.

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.

Satoh K, Kikuchi N, Satoh T, Kurosawa R, Sunamura S, Siddique MAH, Omura J, Yaoita N, Shimokawa H.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4081. doi: 10.3390/ijms19124081. Review.

43.

[ST Segment Elevation on Electrocardiogram (ECG) during Pleural Lavage with Distilled Water;Report of a Case].

Onitsuka T, Sugaya M, Shinohara S, Shimokawa H, Haku S, Wakamatsu M.

Kyobu Geka. 2018 Nov;71(12):1048-1051. Japanese.

PMID:
30449877
44.

Sirtuin 5 promotes ischemia/reperfusion-induced blood-brain barrier damage after stroke.

Satoh K, Shimokawa H.

Int J Cardiol. 2019 Jun 1;284:77-78. doi: 10.1016/j.ijcard.2018.11.019. Epub 2018 Nov 10. No abstract available.

PMID:
30448019
45.

Effects of Hepatitis C Virus Antibody-Positivity on Cardiac Function and Long-Term Prognosis in Patients With Adult Congenital Heart Disease.

Konno R, Tatebe S, Sugimura K, Satoh K, Aoki T, Miura M, Yamamoto S, Sato H, Kozu K, Terui Y, Miyata S, Adachi O, Kimura M, Saiki Y, Shimokawa H.

Am J Cardiol. 2018 Dec 1;122(11):1965-1971. doi: 10.1016/j.amjcard.2018.08.045. Epub 2018 Sep 8.

PMID:
30442226
46.

Viewpoint: Recent Advances in Intracoronary Imaging for Vasa Vasorum Visualisation.

Nishimiya K, Matsumoto Y, Shimokawa H.

Eur Cardiol. 2017 Dec;12(2):121-123. doi: 10.15420/ecr.2017:13:1. Review.

47.

The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study.

Kasahara S, Sakata Y, Nochioka K, Tay WT, Claggett BL, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Sugimura K, Teng TK, Miyata S, Shimokawa H.

Int J Cardiol. 2019 Jun 1;284:42-49. doi: 10.1016/j.ijcard.2018.10.076. Epub 2018 Oct 24.

PMID:
30413304
48.

Prognostic impact of residual stenosis after percutaneous coronary intervention in patients with ischemic heart failure - A report from the CHART-2 study.

Hao K, Takahashi J, Sakata Y, Miyata S, Shiroto T, Nochioka K, Miura M, Oikawa T, Abe R, Sato M, Kasahara S, Aoyanagi H, Shimokawa H; CHART-2 Investigators.

Int J Cardiol. 2019 Mar 1;278:22-27. doi: 10.1016/j.ijcard.2018.10.062. Epub 2018 Oct 18.

PMID:
30366856
49.

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation.

Yamamoto S, Nagasawa T, Sugimura K, Kanno A, Tatebe S, Aoki T, Sato H, Kozu K, Konno R, Nochioka K, Satoh K, Shimokawa H.

Intern Med. 2019 Feb 15;58(4):603-607. doi: 10.2169/internalmedicine.0959-18. Epub 2018 Oct 17.

50.

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).

Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ.

Eur Heart J. 2018 Oct 7;39(38):3499-3507. doi: 10.1093/eurheartj/ehy310.

PMID:
30165610

Supplemental Content

Loading ...
Support Center